Rigel Pharmaceuticals | Eiendeler

Assets Endring Dato
Arrowhead Research USD 626.29M 139.27M 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Celldex Therapeutics USD 465.63M 185.37M 2023-12
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Veracyte USD 1.11B 10.04M 2023-12



Rigel Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.